Item 8.01 Other Events.
On July 14, 2022, Vivos Therapeutics, Inc. (the "Company") issued a press
release announcing that the Company has received multiple Class I clearances by
the Therapeutic Goods Administration (TGA) of Australia, a Tier 1 regulatory
body for multiple indications to include the treatment of snoring and
obstructive sleep apnea (mild, moderate and severe) for both adults and children
for its series of oral appliances.
The Company's press release relating to clearances by the Therapeutic Goods
Administration (TGA) of Australia is filed as Exhibit 99.1 hereto.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. Description
99.1 Press Release of the Company, dated July 14, 2022.
104 Cover Page Interactive Data File (embedded within the Inline XBRL
document)
2
© Edgar Online, source Glimpses